{
    "clinical_study": {
        "@rank": "60", 
        "arm_group": [
            {
                "arm_group_label": "Arm 1", 
                "arm_group_type": "Experimental", 
                "description": "Desipramine, low, middle or high exposure"
            }, 
            {
                "arm_group_label": "Arm 2", 
                "arm_group_type": "Experimental", 
                "description": "Fluoxetine, low, middle, or high exposure"
            }, 
            {
                "arm_group_label": "Arm 3", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Benztropine .125-.5mg daily"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether different types of antidepressant\n      medicines relieve back pain that has lasted at least six months on a daily basis.  Study\n      participants will be assigned to treatment with either a antidepressant acting on the\n      serotonin system in the brain (fluoxetine), one acting on the noradrenaline system\n      (desipramine, or to a control medication not expected to relieve pain (benztropine).  Each\n      participant will be seen at least nine times during their 12 weeks on medication.  This is a\n      phase 2/3, outpatient study."
        }, 
        "brief_title": "Effect of Antidepressants on Back Pain", 
        "completion_date": {
            "#text": "March 2004", 
            "@type": "Actual"
        }, 
        "condition": [
            "Back Pain", 
            "Sciatica"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Back Pain", 
                "Sciatica"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Chronic back pain (pain on a daily basis for  six months or longer)\n\n          -  Age 18-65\n\n          -  No major medical illness\n\n        Exclusion Criteria:\n\n          -  medical contraindication to tricyclic antidepressants\n\n          -  recent alcohol or substance use disorder\n\n          -  bipolar disorder"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": {
            "#text": "130", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "July 3, 2001", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00018200", 
            "org_study_id": "ADRD-018-98F"
        }, 
        "intervention": [
            {
                "arm_group_label": "Arm 1", 
                "description": "Low exposure (40-70 ng/mL), Middle exposure (70-130 ng/mL), High exposure (130-200 ng/mL)", 
                "intervention_name": "Desipramine", 
                "intervention_type": "Drug", 
                "other_name": "Anafranil"
            }, 
            {
                "arm_group_label": "Arm 2", 
                "description": "Low exposure (200-399 ng/mL), Middle exposure (400-499 ng/mL), High exposure (500-700ng/mL)", 
                "intervention_name": "Fluoxetine", 
                "intervention_type": "Drug", 
                "other_name": "Prozac"
            }, 
            {
                "arm_group_label": "Arm 3", 
                "description": "Daily dose 0.125 to 0.5mg", 
                "intervention_name": "Benztropine", 
                "intervention_type": "Drug", 
                "other_name": "Cogentin"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Antidepressive Agents", 
                "Desipramine", 
                "Fluoxetine", 
                "Benztropine"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "analgesia", 
            "Back pain", 
            "sciatica"
        ], 
        "lastchanged_date": "June 4, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "San Diego", 
                    "country": "United States", 
                    "state": "California", 
                    "zip": "92161"
                }, 
                "name": "VA San Diego Healthcare System, San Diego"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "3", 
        "official_title": "Efficacy of Antidepressants in Chronic Back Pain", 
        "overall_official": {
            "affiliation": "VA San Diego Healthcare System, San Diego", 
            "last_name": "Joseph H. Atkinson, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "December 2003", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Descriptor Differential Scale Pain Intensity", 
            "safety_issue": "No", 
            "time_frame": "12 weeks post baseline"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00018200"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "results_reference": {
            "PMID": "17414235", 
            "citation": "Atkinson JH, Slater MA, Capparelli EV, Wallace MS, Zisook S, Abramson I, Matthews SC, Garfin SR. Efficacy of noradrenergic and serotonergic antidepressants in chronic back pain: a preliminary concentration-controlled trial. J Clin Psychopharmacol. 2007 Apr;27(2):135-42."
        }, 
        "source": "Department of Veterans Affairs", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Department of Veterans Affairs", 
                "agency_class": "U.S. Fed"
            }
        }, 
        "start_date": "April 1999", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2012"
    }, 
    "geocoordinates": {
        "VA San Diego Healthcare System, San Diego": "32.715 -117.157"
    }
}